{"transactions":[{"id":1870271,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-02T20:31:33.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 31, 2023, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":14500,"derivative":{"exercise_price":14.47,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0001209191-23-033769","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123033769/doc4.xml","form_type":"4"}},{"id":2231610,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T20:40:02.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following June 13, 2022, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders,  subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":14500,"derivative":{"exercise_price":5.38,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0001209191-22-036966","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919122036966/doc4.xml","form_type":"4"}},{"id":2566265,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-09-17T20:42:49.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":7290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18935},"source":{"system":"sec-edgar","filing":"0000899243-21-036424","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000089924321036424/doc4.xml","form_type":"4"}},{"id":2566264,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-09-17T20:42:49.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":16366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":42509},"source":{"system":"sec-edgar","filing":"0000899243-21-036424","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000089924321036424/doc4.xml","form_type":"4"}},{"id":2566263,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-17T20:42:49.000Z","date":"2021-09-17","kind":"exercise","acquired":true,"shares":61444,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 37,105 shares subject to repurchase by us, which are subject to vesting."}],"balance_after":192783,"source":{"system":"sec-edgar","filing":"0000899243-21-036424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000089924321036424/doc4.xml","form_type":"4"}},{"id":3150292,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Options","published_at":"2020-05-13T16:18:50.000Z","date":"2020-05-11","kind":"exercise","acquired":false,"shares":33334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":23420,"derivative":{"exercise_price":24.99,"expiration_date":"2026-01-21","underlying":"Common Stock","underlying_shares":33334},"source":{"system":"sec-edgar","filing":"0001214659-20-004484","document":"marketforms-48772.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465920004484/marketforms-48772.xml","form_type":"4"}},{"id":3150291,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-05-13T16:18:50.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":33334,"price":105,"value":3500070.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 2, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $105.00 to $105.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":39401,"source":{"system":"sec-edgar","filing":"0001214659-20-004484","document":"marketforms-48772.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465920004484/marketforms-48772.xml","form_type":"4"}},{"id":3150290,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-05-13T16:18:50.000Z","date":"2020-05-11","kind":"exercise","acquired":true,"shares":33334,"price":24.99,"value":833016.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 2, 2019."}],"balance_after":72735,"source":{"system":"sec-edgar","filing":"0001214659-20-004484","document":"marketforms-48772.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465920004484/marketforms-48772.xml","form_type":"4"}},{"id":3296290,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Options","published_at":"2020-01-31T20:03:28.000Z","date":"2020-01-29","kind":"exercise","acquired":false,"shares":3002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":56754,"derivative":{"exercise_price":24.99,"expiration_date":"2026-01-21","underlying":"Common Stock","underlying_shares":3002},"source":{"system":"sec-edgar","filing":"0001214659-20-000769","document":"marketforms-47609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465920000769/marketforms-47609.xml","form_type":"4"}},{"id":3296289,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-01-31T20:03:28.000Z","date":"2020-01-29","kind":"exercise","acquired":true,"shares":3002,"price":24.99,"value":75019.98,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 392 shares acquired under the ESPP Purchase on 05/31/2019 and 171 shares acquired under the ESPP purchase on 11/29/2019."}],"balance_after":39401,"source":{"system":"sec-edgar","filing":"0001214659-20-000769","document":"marketforms-47609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465920000769/marketforms-47609.xml","form_type":"4"}},{"id":3686488,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-25T19:00:17.000Z","date":"2019-01-23","kind":"exercise","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":49997,"derivative":{"exercise_price":5.4,"expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0001214659-19-000538","document":"marketforms-43790.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465919000538/marketforms-43790.xml","form_type":"4"}},{"id":3686487,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-25T19:00:17.000Z","date":"2019-01-23","kind":"exercise","acquired":false,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":25283,"derivative":{"exercise_price":21.51,"expiration_date":"2025-02-03","underlying":"Common Stock","underlying_shares":625},"source":{"system":"sec-edgar","filing":"0001214659-19-000538","document":"marketforms-43790.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465919000538/marketforms-43790.xml","form_type":"4"}},{"id":3686486,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Options","published_at":"2019-01-25T19:00:17.000Z","date":"2019-01-23","kind":"exercise","acquired":false,"shares":244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":59756,"derivative":{"exercise_price":24.99,"expiration_date":"2026-01-21","underlying":"Common Stock","underlying_shares":244},"source":{"system":"sec-edgar","filing":"0001214659-19-000538","document":"marketforms-43790.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465919000538/marketforms-43790.xml","form_type":"4"}},{"id":3686485,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-25T19:00:17.000Z","date":"2019-01-23","kind":"exercise","acquired":true,"shares":1,"price":5.4,"value":5.4,"ownership":{"direct":true},"balance_after":35836,"source":{"system":"sec-edgar","filing":"0001214659-19-000538","document":"marketforms-43790.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465919000538/marketforms-43790.xml","form_type":"4"}},{"id":3686484,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-25T19:00:17.000Z","date":"2019-01-23","kind":"exercise","acquired":true,"shares":625,"price":21.51,"value":13443.75,"ownership":{"direct":true},"balance_after":35835,"source":{"system":"sec-edgar","filing":"0001214659-19-000538","document":"marketforms-43790.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465919000538/marketforms-43790.xml","form_type":"4"}},{"id":3686483,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-25T19:00:17.000Z","date":"2019-01-23","kind":"exercise","acquired":true,"shares":244,"price":24.99,"value":6097.56,"ownership":{"direct":true},"balance_after":35210,"source":{"system":"sec-edgar","filing":"0001214659-19-000538","document":"marketforms-43790.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465919000538/marketforms-43790.xml","form_type":"4"}},{"id":3690440,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Option Grant (Right to Buy)","published_at":"2019-01-22T19:00:43.000Z","date":"2019-01-17","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":60000,"derivative":{"exercise_price":64.14,"expiration_date":"2029-01-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001214659-19-000461","document":"marketforms-43744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465919000461/marketforms-43744.xml","form_type":"4"}},{"id":3865944,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-07-17T19:00:16.000Z","date":"2018-07-16","kind":"exercise","acquired":false,"shares":1592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":25908,"derivative":{"exercise_price":21.51,"expiration_date":"2025-02-03","underlying":"Common Stock","underlying_shares":1592},"source":{"system":"sec-edgar","filing":"0001214659-18-004880","document":"marketforms-42472.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465918004880/marketforms-42472.xml","form_type":"4"}},{"id":3865943,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-07-17T19:00:16.000Z","date":"2018-07-16","kind":"exercise","acquired":false,"shares":275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":5913,"derivative":{"exercise_price":17.41,"expiration_date":"2024-05-20","underlying":"Common Stock","underlying_shares":275},"source":{"system":"sec-edgar","filing":"0001214659-18-004880","document":"marketforms-42472.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465918004880/marketforms-42472.xml","form_type":"4"}},{"id":3865942,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-07-17T19:00:16.000Z","date":"2018-07-16","kind":"exercise","acquired":true,"shares":1592,"price":21.51,"value":34243.92,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 879 shares acquired under the ESPP Purchase on 05/31/18."}],"balance_after":34582,"source":{"system":"sec-edgar","filing":"0001214659-18-004880","document":"marketforms-42472.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465918004880/marketforms-42472.xml","form_type":"4"}},{"id":3865941,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-07-17T19:00:16.000Z","date":"2018-07-16","kind":"exercise","acquired":true,"shares":275,"price":17.41,"value":4787.75,"ownership":{"direct":true},"balance_after":32111,"source":{"system":"sec-edgar","filing":"0001214659-18-004880","document":"marketforms-42472.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465918004880/marketforms-42472.xml","form_type":"4"}},{"id":3955948,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-04-26T18:07:50.000Z","date":"2018-04-25","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":27500,"derivative":{"exercise_price":21.51,"expiration_date":"2025-02-03","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001214659-18-003060","document":"marketforms-41802.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465918003060/marketforms-41802.xml","form_type":"4"}},{"id":3955947,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-04-26T18:07:50.000Z","date":"2018-04-25","kind":"exercise","acquired":false,"shares":412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":6188,"derivative":{"exercise_price":17.41,"expiration_date":"2024-05-20","underlying":"Common Stock","underlying_shares":412},"source":{"system":"sec-edgar","filing":"0001214659-18-003060","document":"marketforms-41802.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465918003060/marketforms-41802.xml","form_type":"4"}},{"id":3955946,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-04-26T18:07:50.000Z","date":"2018-04-25","kind":"exercise","acquired":false,"shares":10124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":96668,"derivative":{"exercise_price":15.79,"expiration_date":"2023-11-07","underlying":"Common Stock","underlying_shares":10124},"source":{"system":"sec-edgar","filing":"0001214659-18-003060","document":"marketforms-41802.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465918003060/marketforms-41802.xml","form_type":"4"}},{"id":3955945,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-04-26T18:07:50.000Z","date":"2018-04-25","kind":"exercise","acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":49998,"derivative":{"exercise_price":5.4,"expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0001214659-18-003060","document":"marketforms-41802.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465918003060/marketforms-41802.xml","form_type":"4"}},{"id":3955944,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-26T18:07:50.000Z","date":"2018-04-25","kind":"exercise","acquired":true,"shares":2500,"price":21.51,"value":53775.0,"ownership":{"direct":true},"balance_after":31836,"source":{"system":"sec-edgar","filing":"0001214659-18-003060","document":"marketforms-41802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465918003060/marketforms-41802.xml","form_type":"4"}},{"id":3955943,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-26T18:07:50.000Z","date":"2018-04-25","kind":"exercise","acquired":true,"shares":412,"price":17.41,"value":7172.92,"ownership":{"direct":true},"balance_after":29336,"source":{"system":"sec-edgar","filing":"0001214659-18-003060","document":"marketforms-41802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465918003060/marketforms-41802.xml","form_type":"4"}},{"id":3955942,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-26T18:07:50.000Z","date":"2018-04-25","kind":"exercise","acquired":true,"shares":10124,"price":15.79,"value":159857.96,"ownership":{"direct":true},"balance_after":28924,"source":{"system":"sec-edgar","filing":"0001214659-18-003060","document":"marketforms-41802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465918003060/marketforms-41802.xml","form_type":"4"}},{"id":3955941,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-26T18:07:50.000Z","date":"2018-04-25","kind":"exercise","acquired":true,"shares":2,"price":5.4,"value":10.8,"ownership":{"direct":true},"balance_after":18800,"source":{"system":"sec-edgar","filing":"0001214659-18-003060","document":"marketforms-41802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465918003060/marketforms-41802.xml","form_type":"4"}},{"id":4093490,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Option Grant (Right to Buy)","published_at":"2018-01-22T18:00:13.000Z","date":"2018-01-18","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":50000,"derivative":{"exercise_price":27,"expiration_date":"2028-01-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001214659-18-000576","document":"marketforms-40829.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000121465918000576/marketforms-40829.xml","form_type":"4"}},{"id":4476991,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":112831,"kind":"person","name":"CHEN ISAN","position":1,"cik":"0001586218","reported_name":"CHEN ISAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Chief Medical"}}],"security":"Option Grant (Right to Buy)","published_at":"2017-01-30T18:07:49.000Z","date":"2017-01-26","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":50000,"derivative":{"exercise_price":5.4,"expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001190725-17-000027","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000119072517000027/primary_doc.xml","form_type":"4"}}]}